DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Gilead Sciences (NASDAQ: GILD)



company name or ticker
Company Photos
(Click to zoom)

Mixed Readings For Biotech Short Interest

Should Gilead Sciences, Inc. Pay a Dividend?

Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?

#PreMarket Primer: Wednesday, November 26: Big Retailers Gear Up For Black Friday

Dow Chemical, NXP Semi, Gilead Sciences Set for Gains, Lucia Capital CEO Says

For Gilead, Are Products More Important Than Price?

Why You Shouldn't Bet Against Gilead Sciences (GILD) Stock - Tale of the Tape

3 Stocks Underperforming Today In The Drugs Industry

3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie

Gilead Sciences hepatitis C drug Harvoni offers three important advantages over AbbVie's competing hepatitis C drug cocktail.

Despite Recent Hiccup, Gilead Is Still A Blue Chip Gem

3 Biotech Growth Stocks You Can Buy Right Now

These three biotech growth stocks may have already delivered impressive gains to investors, but there could still be plenty of room left for them to head even higher.
See More Articles...